Clinical Trials Directory

Trials / Terminated

TerminatedNCT00988442

Telephone Support to Improve Adherence to Anti-HIV Medications

A Randomized Trial of Enhanced Nursing Telephone Support to Improve Medication Self-Management and Viral Outcomes of Antiretroviral Therapy-Experienced Patients

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study tested a system of nursing telephone support to determine if it improves adherence to antiretroviral therapy (ART) in at-risk, treatment-experienced people.

Detailed description

Antiretroviral therapy (ART) is only successful in treating HIV when people take all the medications prescribed to them when and how they are instructed. However, a third or more of patients on ART are not able to adhere to their medication regimens. Therefore, making sure that these patients stay healthy involves making sure they are motivated and informed about the importance of adhering to their ART. Nurses can deliver interventions to motivate and inform patients through regularly scheduled phone calls. These calls allow nurses to check in between clinic visits, are convenient to patients, and are cost efficient. This study tested an enhanced telephone support intervention provided by nurses that aimed to improve ART adherence and treatment outcomes. Follow-up for this study lasted 72 weeks. Participants were randomly assigned to receive either care as usual or the enhanced telephone support intervention plus care as usual. The telephone support intervention involved phone calls made weekly for the first 8 weeks of the study and then every 2 weeks for the next 40 weeks. Nurses made these calls at a time and place participants chose. During the calls, nurses provided information, motivational enhancement, and problem-solving skills. Study assessments took place at study entry and after 12, 24, 48, and 72 weeks. Assessments measured CD4 cell count, HIV viral load, adherence, and illness events. Adherence was measured through questionnaires and an electronic pill cap. This study was closed early to both accrual and follow-up due to low recruitment. The study aimed to enroll 296 participants. The actual study accrual at the time of early closing was 59 participants.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEnhanced nursing telephone supportWeekly phone calls by study nurses for 8 weeks and then calls every 2 weeks for 40 weeks; nurses could schedule more frequent calls at their discretion. Calls provided information, motivational enhancement, problem-solving skills, and affective support.
BEHAVIORALStandard careUsual ACTG site care.

Timeline

Start date
2010-10-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2009-10-02
Last updated
2017-07-17
Results posted
2017-07-17

Locations

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00988442. Inclusion in this directory is not an endorsement.